Shine-On BioMedical Co.,Ltd.

TPEX:6926 Stock Report

Market Cap: NT$3.3b

Shine-On BioMedicalLtd Balance Sheet Health

Financial Health criteria checks 6/6

Shine-On BioMedicalLtd has a total shareholder equity of NT$1.1B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.1B and NT$21.8M respectively.

Key information

0%

Debt to equity ratio

NT$0

Debt

Interest coverage ration/a
CashNT$1.09b
EquityNT$1.09b
Total liabilitiesNT$21.76m
Total assetsNT$1.11b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 6926's short term assets (NT$1.1B) exceed its short term liabilities (NT$19.7M).

Long Term Liabilities: 6926's short term assets (NT$1.1B) exceed its long term liabilities (NT$2.1M).


Debt to Equity History and Analysis

Debt Level: 6926 is debt free.

Reducing Debt: 6926 has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 6926 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: 6926 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 49.6% each year


Discover healthy companies